@article{7d9c9ecd309744b3a8b707bdcc1513da,
title = "Renal dysfunction increases the risk of recurrent stroke in patients with acute ischemic stroke",
abstract = "Background and aims: This study investigated risks of short-term (1 and 3 months) and long-term (1-year) recurrent stroke associated with glomerular filtration rate (eGFR) in patients with acute ischemic stroke. Methods: From the Taiwan Stroke Registry data, we identified 45,876 acute ischemic stroke patients from April 2006 to April 2014 and classified them into 4 groups based on the eGFR at admission: ≥ 90, 60–89, 30–59, and <30 mL/min/1.73 m2 or on dialysis. The risks of 1-month, 3-month and 1-year recurrent stroke related to the eGFR levels were investigated. Results: Both the risks of short-term and long-term recurrent stroke increased as the eGFR levels declined. The 1-month recurrent incidence rates increased steadily from 0.54 to 0.59, 0.84 and 0.89 per 1000 person-days, as the eGFR declined from ≥90 to 60–89, 30–59, and <30 mL/min/1.73 m2 or on dialysis, respectively. Compared to patients with eGFR ≥90 mL/min/1.73 m2, the adjusted subhazard ratio of 1-month recurrent stroke decreased from 1.69 (95% confidence interval (CI) = 1.24–2.31) for patients with eGFR < 30 mL/min/1.73 m2 or on dialysis to 1.14 (95% CI = 0.91–1.43) for patients with eGFRs of 60–89 mL/min/1.73 m2, considering the competing risk of deaths. Similar patterns were also observed for the adjusted HRs of 3-month and 1-year recurrent stroke, but with reduced hazard values, by the corresponding eGFR levels. Conclusions: There is an independent graded association between an increased risk of recurrent stroke and declining eGFR levels in patients with acute ischemic stroke.",
keywords = "Estimated glomerular filtration rate, Ischemic stroke, Recurrent stroke, Renal function",
author = "{Taiwan Stroke Registry Investigators} and Wang, {I. Kuan} and Lien, {Li Ming} and Lee, {Jiunn Tay} and Liu, {Chung Hsiang} and Chen, {Chih Hung} and Lin, {Ching Huang} and Jeng, {Jiann Shing} and Hu, {Chaur Jong} and Yen, {Tzung Hai} and Chen, {Sien Tsong} and Chiu, {Hou Chang} and Tsai, {I. Ju} and Sung, {Fung Chang} and Hsu, {Chung Y.}",
note = "Funding Information: This study is supported in part by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), Children's Hospital of China Medical University (DMR-106-052), China Medical University Hospital (DMR-107-026 and DMR-107-176), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10701010021), Taiwan Clinical Trial Consortium for Stroke(MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. Funding Information: This study is supported in part by grants from the Ministry of Health and Welfare, Taiwan ( MOHW107-TDU-B-212-123004 ), Children's Hospital of China Medical University ( DMR-106-052 ), China Medical University Hospital ( DMR-107-026 and DMR-107-176 ), Academia Sinica Taiwan Biobank Stroke Biosignature Project ( BM10701010021 ), Taiwan Clinical Trial Consortium for Stroke ( MOST 106-2321-B-039-005 ), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. Publisher Copyright: {\textcopyright} 2018 Elsevier B.V.",
year = "2018",
month = oct,
day = "1",
doi = "10.1016/j.atherosclerosis.2018.07.033",
language = "English",
volume = "277",
pages = "15--20",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
}